US antiviral drugs panel to meet in closed session
This article was originally published in Scrip
Executive Summary
The US FDA's antiviral drugs advisory panel will meet in closed session on October 30th to discuss current and future advances on antiviral drugs, including a review of trade secret or confidential information.